You are here

Plant-based vaccine makers take on big boys

Their production method may turn out to be faster, cheaper

New York

TWO tiny companies are preparing to challenge some of the largest drug makers in the battle for dominance in the US$3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.

The use of plants to produce life-saving pharmaceuticals